Wockhardt Limited

Wockhardt Limited (WOCKPHARMA) is a mid-cap Healthcare company valued at ₹31,673 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Wockhardt Limited last traded at ₹1,954.9, modestly up 0.28% on the day.

Recent developments

2026-09-21: Pharma stocks rallied, with Wockhardt leading gains. 2026-09-07: Wockhardt shares rose 7%, extending gains for the fourth consecutive session, marking the stock's biggest gain on the Nifty Pharma index.

Financial performance

The company's business improved significantly, with annual net profit swinging from a loss to a profit and the net profit margin rising 7.8 percentage points. The latest quarter showed a sharp turnaround, with net profit turning positive and revenue rising 25.9% compared to the same quarter a year earlier.

Valuation multiples

The stock trades at 149.0 times earnings, a premium to the Healthcare median of 32.0, 7.30 times book value.

Things to watch

The stock is 19.3% below its 52-week high, and the company's profit has declined over the past five years. The net profit margin, while improved, remains low at 5.9%.

Where it stands

The company has turned around its profitability, with the latest quarter showing a strong recovery. The stock's performance has been positive recently, but it is still below its 52-week high. The most significant movement was the swing to profit in the latest quarter.

Summarised by DocStoX's model on 2026-10-17 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.